Inactivation of the p16 gene by hypermethylation and loss of heterozygosity in adenocarcimoma of the lung

Pathology International

Volumn 54, Issue 7, 2004, Pages 486-489

  Awaya, Hirokazu ^a   Takeshima, Yukio ^a   Amatya, Vishwa Jeet ^a   Furonaka, Osamu ^a   Tagawa, Kohei ^b   Kohno, Nobuoki ^a   Inai, Kouki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b MAZDA HOSPITAL   (Japan)

Author keywords

Adenocarcinoma; Loss of heterozygosity; Lung; Methylation; p14; p15; p16

Indexed keywords

KI 67 ANTIGEN; PROTEIN P14; PROTEIN P15; PROTEIN P16;

ADULT; AGED; ALLELE; ARTICLE; CANCER GRADING; CHROMOSOME 9P; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA METHYLATION; EARLY DIAGNOSIS; FEMALE; GENE FREQUENCY; GENE INACTIVATION; GENE LOCUS; GENETIC CORRELATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG CARCINOGENESIS; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEPLETION; PROTEIN EXPRESSION; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; DNA, NEOPLASM; GENE SILENCING; GENES, P16; HUMANS; IMMUNOHISTOCHEMISTRY; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; MICROSATELLITE REPEATS; MIDDLE AGED; POLYMERASE CHAIN REACTION;

EID: 3242661541     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2004.01655.x     Document Type: Article

References (32)

1. Li Mao. Molecular abnormalities in lung carcinogenesis and their potential clinical implications. Lung Cancer 2001; 34: S27-34.
2. Garinis GA, Patrinos GP, Spanakis NE, Menounos PG. DNA hypermethylation: when tumour suppressor genes go silent. Hum Genet 2002; 111: 115-27.
3. Tucker T, Friedman JM. Pathogenesis of hereditary tumors: beyond the 'two-hit' hypothesis. Clin Genet 2002; 62: 345-57.
4. Jone PA, Laird PW. Cancer-epigenetics comes of age. Nature Genet 1999; 21: 163-7.
5. Sheer CJ. The Pezcoller Lecture. Cancer cell cycles revisited. Cancer Res 2000; 60: 3689-95.
6. Zhang Y, Xiong Y, Yarbrough WG. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 1998; 92: 725-34.
7. Kim DH, Nelson HH, Wiencke JK et al. P16 (INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer. Cancer Res 2001; 61: 3419-24.
8. Belinsky SA, Nikula KJ, Palmisano WA et al. Aberrant methylation of p16INK4a is an early event in lung cancer and a potential biomarker for early diagnosis. Proc Natl Acad Sci USA 1998; 95: 11 891-6.
9. Kamijo T, Zindy F, Roussel MF et al. Tumor suppressions at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 1997; 91: 649-59.
10. Travis WD, Colby TV, Corrin B et al., eds. Histological Typing of Lung and Pleural Tumours. Geneva: WHO, 1999.
11. Herman JG, Graff JR, Myohansen S, Nelkin BD, Baylin SB. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996; 93: 9821-6.
12. Tagawa K, Arihiro K, Takeshima Y, Hiyama E, Yamasaki M, Inai K. Down-regulation of KAI1 messenger RNA expression is not associated with loss of heterozygosity of the KAI1 gene region in lung adenocarcinoma. Jpn J Cancer Res 1999; 90: 970-76.
13. Zochbauer-Muller S, Fong KM, Virmani AK, Geradts J, Gazdar AF, Minna JD. Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Res 2001; 61: 249-55.
14. Maruyama R, Toyooka S, Toyooka K et al. Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features. Clin Cancer Res 2002; 8: 514-19.
15. Kuijper A, Buerger H, Simon R et al. Analysis of the progression of fibroepithelial tumours of the breast by PCR-based clonarity assay. J Pathol 2002; 197: 575-81.
16. Takeshima Y, Yamasaki M, Nishisaka T, Kitaguchi S, Inai K. P21WAF/CIP1 expression in primary lung adenocarcinomas: heterogenous expression in tumor tissues and correlation with p53 expression and proliferative activities. Carcinogenesis 1998; 19: 1755-61.
17. Gazzeri S, Gouyer V, Vour'ch C, Brambilla C, Brambilla E. Mechanisms of p16INK4A inactivation in non small-cell lung cancers. Oncogene 1998; 16: 497-504.
18. Knudson AG. Mutation and cancer. Statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971; 68: 820-23.
19. Okano M, Bell DW, Haber DA, Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 1999; 99: 247-57.
20. Myohanen SK, Baylin SB, Herman JG. Hypermethylation can selectively silence individual p16ink4A alleles in neoplasia. Cancer Res 1998; 58: 591-3.
21. Batova A, Diccianni MB, Yu JC et al. Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic leukemia. Cancer Res 1997; 57: 832-6.
22. Hiltunen MO, Alhonen L, Koistinaho J. Hypermethylation of the APC (adenomatous polyposis coli) gene promoter region in human colorectal carcinoma. Int J Cancer 1997; 70: 644-8.
23. Prowse AH, Webster AR, Richards FM et al. Somatic inactivation of the VHL gene in von Hippel-Lindau disease tumors. Am J Hum Genet 1997; 60: 765-71.
24. Takeshima Y, Nishisaka T, Kawano R et al. p16/CDKN2 gene and p53 gene alterations in Japanese non-smoking female lung adenocarcinoma. Jpn J Cancer Res 1996; 87: 134-40.
25. Niklinska W, Chyczewski L, Laudanski J, Chyczewska E, Niklinski J. Detection of p16 abnormalities in early-stage non-small cell lung cancer. Folia Histochem Cytobiol 2001; 39: 30-32.
26. Su CYeY, Wang D. Correlation between methylation on Smal locus of the CDKN2/p16 gene CpG island and lung cancer. Zhonghua Zhong Liu Za Zhi 2000; 22: 471-3.
27. Kim DH, Nelson HH, Wiencke JK et al. p16INK4a and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer. Cancer Res 2001; 61: 3419-24.
28. Packenham JP, Taylor JA, White CM, Anna CH, Barrett JC, Devereu TR. Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers. Clin Cancer Res 1995; 1: 687-90.
29. Yang Q, Nakamura M, Nakamura Y et al. Two-hit inactivation of FHIT by loss of heterozygosity and hypermethylation in breast cancer. Clin Cancer Res 2002; 8: 2890-93.
30. Mariatos G, Gorgoulis VG, Zacharatos P et al. Expression of p16INK4A and alteration of the 9p21-23 chromosome region in non-small-cell lung carcinomas: relationship with tumor growth parameters and ploidy status. Int J Cancer 2000; 89: 133-41.
31. Kurakawa E, Shimamoto T, Utsumi K, Hirano T, Kato H, Ohyashiki K. Hypermethylation of p16 (INK4a) and p15 (INK4b) genes in non-small cell lung cancer. Int J Oncol 2001; 19: 277-81.
32. Palmisano WA, Divine KK, Saccomanno G et al. Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res 2000; 60: 5954-8.